Pharmacokinetics of anti-onchocerciasis preparations. 1. Suramin in standard and decreased doses
Ovusu, A.; Lur'e, A.A.; Petrov, O.E.; Ozeretskovskaia, N.N.
Meditsinskaia Parazitologiia i Parazitarnye Bolezni 5: 40-44
1984
ISSN/ISBN: 0025-8326 PMID: 6513873 Document Number: 226598
Document emailed within 1 workday
Related Documents
Awadzi, K.; Hero, M.; Opoku, N.O.; Büttner, D.W.; Coventry, P.A.; Prime, M.A.; Orme, M.L.; Edwards, G. 1994: The chemotherapy of onchocerciasis XVII. A clinical evaluation of albendazole in patients with onchocerciasis; effects of food and pretreatment with ivermectin on drug response and pharmacokinetics Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 45(3): 203-208Orme, M.; Edwards, G.; Awadzi, K.; Breckenridge, A. 1990: Clinical pharmacokinetics of drugs against onchocerciasis Acta Leidensia 59(1-2): 329-342
Motzer, R.J.; Nanus, D.M.; O'Moore, P.; Scher, H.I.; Bajorin, D.F.; Reuter, V.; Tong, W.P.; Iversen, J.; Louison, C.; Albino, A.P. 1992: Phase II trial of suramin in patients with advanced renal cell carcinoma: treatment results, pharmacokinetics, and tumor growth factor expression Cancer Research 52(20): 5775-5779
Alvarez Gordillo, G.C.; Rivas Alcalá, A.R. 1991: Changes in the peripheral leukocytes of onchocerciasis patients treated with consecutive doses of ivermectin Salud Publica de Mexico 33(2): 112-123
Lecaillon, J.B.; Poltera, A.A.; Zea-Flores, G.; de Ramirez, I.; Nowell de Arevalo, A. 1991: Influence of food related to dose on the pharmacokinetics of amocarzine and of its N-oxide metabolite, CGP 13 231, after oral administration to 20 onchocerciasis male patients from Guatemala Tropical Medicine and Parasitology: Official Organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft für Technische Zusammenarbeit 42(3): 286-290
Barocci, S.; Fenoglio, D.; Leprini, A.; Nocera, A. 1990: Anti-HLA antibodies (Ab1) and anti-idiotypic antibodies (Ab2) directed against Anti-HLA Ab1 in various preparations of polyspecific immunoglobulins for intravenous use Bollettino della Societa Italiana di Biologia Sperimentale 66(12): 1193-1200
Campos-Outcalt, D. 2008: Varicella vaccination: 2 doses now the standard Journal of Family Practice 57(1): 38-40
Ashley, K.C. 1986: The anti-bacterial activity of topical anti-infective eye preparations Medical Laboratory Sciences 43(2): 157-162
Beermann, B.; Odlind, B.; Wibell, L. 1983: Diuretic effect and pharmacokinetics of tizolemide in subjects with normal and decreased renal function Clinical Nephrology 19(3): 124-131
Fürst, W.; Roth, B.; Albrecht, G. 1985: The stability of griseofulvin in standard preparations Die Pharmazie 40(1): 65
Noma, M.; Nwoke, B.E.B.; Nutall, I.; Tambala, P.A.; Enyong, P.; Namsenmo, A.; Remme, J.; Amazigo, U.V.; Kale, O.O.; Seketeli, A. 2002: Rapid epidemiological mapping of onchocerciasis Its application by the African Programme for Onchocerciasis Control Annals of Tropical Medicine and Parasitology 96(Suppl 1): S29-S39
Carabin, Hélène.; Escalona, M.; Marshall, C.; Vivas-Martínez, S.; Botto, C.; Joseph, L.; Basáñez, Mía-Gloria. 2003: Prediction of community prevalence of human onchocerciasis in the Amazonian onchocerciasis focus: Bayesian approach Bulletin of the World Health Organization 81(7): 482-490
2009: Onchocerciasis (river blindness). Report from the eighteenth InterAmerican Conference on Onchocerciasis, November 2008 Releve Epidemiologique Hebdomadaire 84(38): 385-389
Leone, N.; Barzaghi, N.; Monteleone, M.; Perucca, E.; Cerutti, R.; Crema, A. 1987: Pharmacokinetics of co-trimazine after single and multiple doses Arzneimittel-Forschung 37(1): 70-74
Ramis, J.; Torrent, J.; Mis, R.; Conte, L.; Barbanoj, M.J.; Jané, J.; Forn, J. 1990: Pharmacokinetics of triflusal after single and repeated doses in man International Journal of Clinical Pharmacology Therapy and Toxicology 28(8): 344-349
Mattila, J.; Mäntylä, R.; Vuorela, A.; Lamminsivu, U.; Männistö, P. 1984: Pharmacokinetics of graded oral doses of sulindac in man Arzneimittel-Forschung 34(2): 226-229
Colebunders, R.; Raimon, S.; Siewe Fodjo, J.N.; Carter, J.Y. 2019: Increased cost-benefit of strengthening onchocerciasis elimination efforts in areas with high onchocerciasis-associated epilepsy Tropical Medicine and International Health: Tm and Ih 24(10): 1259
Bergan, T.; Thorsteinsson, S.B.; Solberg, R.; Bjornskau, L.; Kolstad, I.M.; Johnsen, S. 1987: Pharmacokinetics of ciprofloxacin: intravenous and increasing oral doses American Journal of Medicine 82(4a): 97-102
Gikalov, I.; Kaufmann, R.; Schuster, O. 1982: Human pharmacokinetics of different I.v. doses of azapropazone (HPLC-determination) Arzneimittel-Forschung 32(4): 423-426
Setnikar, I.; Chisté, R.; Giacovelli, G.; Rovati, L.C. 1989: Pharmacokinetics and tolerance of repeated oral doses of loxiglumide Arzneimittel-Forschung 39(11): 1454-1459